nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine—ADORA2B—Aminophylline—chronic obstructive pulmonary disease	0.325	0.423	CbGbCtD
Adenosine—ADORA1—Aminophylline—chronic obstructive pulmonary disease	0.235	0.306	CbGbCtD
Adenosine—ADORA2A—Aminophylline—chronic obstructive pulmonary disease	0.208	0.271	CbGbCtD
Adenosine—ADA—pleura—chronic obstructive pulmonary disease	0.0289	0.412	CbGeAlD
Adenosine—SLC28A3—respiratory system—chronic obstructive pulmonary disease	0.0044	0.0627	CbGeAlD
Adenosine—SLC28A3—trachea—chronic obstructive pulmonary disease	0.00325	0.0464	CbGeAlD
Adenosine—ADA—respiratory system—chronic obstructive pulmonary disease	0.00287	0.0409	CbGeAlD
Adenosine—ADORA2B—bronchus—chronic obstructive pulmonary disease	0.00258	0.0368	CbGeAlD
Adenosine—ADORA2B—smooth muscle tissue—chronic obstructive pulmonary disease	0.00252	0.036	CbGeAlD
Adenosine—ADA—connective tissue—chronic obstructive pulmonary disease	0.00252	0.036	CbGeAlD
Adenosine—SLC28A3—lung—chronic obstructive pulmonary disease	0.00234	0.0333	CbGeAlD
Adenosine—ADORA2B—trachea—chronic obstructive pulmonary disease	0.00232	0.033	CbGeAlD
Adenosine—DPP4—respiratory system—chronic obstructive pulmonary disease	0.00227	0.0324	CbGeAlD
Adenosine—DPP4—connective tissue—chronic obstructive pulmonary disease	0.002	0.0285	CbGeAlD
Adenosine—ADK—bronchus—chronic obstructive pulmonary disease	0.00193	0.0275	CbGeAlD
Adenosine—ADK—smooth muscle tissue—chronic obstructive pulmonary disease	0.00189	0.0269	CbGeAlD
Adenosine—DPP4—smooth muscle tissue—chronic obstructive pulmonary disease	0.00183	0.0261	CbGeAlD
Adenosine—ADK—trachea—chronic obstructive pulmonary disease	0.00173	0.0247	CbGeAlD
Adenosine—ADA—C-MYB transcription factor network—ELANE—chronic obstructive pulmonary disease	0.00171	0.0517	CbGpPWpGaD
Adenosine—ADORA2B—lung—chronic obstructive pulmonary disease	0.00166	0.0237	CbGeAlD
Adenosine—ADA—lung—chronic obstructive pulmonary disease	0.00152	0.0217	CbGeAlD
Adenosine—ADORA2B—C-MYB transcription factor network—ELANE—chronic obstructive pulmonary disease	0.0015	0.0453	CbGpPWpGaD
Adenosine—DPP4—Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)—LEP—chronic obstructive pulmonary disease	0.00134	0.0404	CbGpPWpGaD
Adenosine—Glucosamine—MMP9—chronic obstructive pulmonary disease	0.00134	0.491	CrCbGaD
Adenosine—ADK—lung—chronic obstructive pulmonary disease	0.00124	0.0177	CbGeAlD
Adenosine—DPP4—lung—chronic obstructive pulmonary disease	0.00121	0.0172	CbGeAlD
Adenosine—ADORA1—lung—chronic obstructive pulmonary disease	0.0012	0.0171	CbGeAlD
Adenosine—DPP4—Incretin synthesis, secretion, and inactivation—LEP—chronic obstructive pulmonary disease	0.00119	0.036	CbGpPWpGaD
Adenosine—ADORA2A—HIF-2-alpha transcription factor network—MMP14—chronic obstructive pulmonary disease	0.000884	0.0267	CbGpPWpGaD
Adenosine—Glucosamine—TNF—chronic obstructive pulmonary disease	0.000879	0.323	CrCbGaD
Adenosine—ADORA2A—Monoamine Transport—SLC6A4—chronic obstructive pulmonary disease	0.000741	0.0224	CbGpPWpGaD
Adenosine—SLC28A3—Transport of vitamins, nucleosides, and related molecules—ALB—chronic obstructive pulmonary disease	0.000739	0.0223	CbGpPWpGaD
Adenosine—ADA—p73 transcription factor network—SERPINA1—chronic obstructive pulmonary disease	0.000737	0.0222	CbGpPWpGaD
Adenosine—SLC28A3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000685	0.0207	CbGpPWpGaD
Adenosine—ADA—C-MYB transcription factor network—MPO—chronic obstructive pulmonary disease	0.000661	0.02	CbGpPWpGaD
Adenosine—DPP4—Peptide hormone metabolism—ACE—chronic obstructive pulmonary disease	0.000651	0.0196	CbGpPWpGaD
Adenosine—SLC28A3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00061	0.0184	CbGpPWpGaD
Adenosine—ADORA2B—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	0.000593	0.0179	CbGpPWpGaD
Adenosine—ADORA2B—C-MYB transcription factor network—MPO—chronic obstructive pulmonary disease	0.000578	0.0175	CbGpPWpGaD
Adenosine—Tension—Aminophylline—chronic obstructive pulmonary disease	0.000506	0.00398	CcSEcCtD
Adenosine—Tenofovir—CYP1A2—chronic obstructive pulmonary disease	0.000505	0.186	CrCbGaD
Adenosine—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000503	0.00396	CcSEcCtD
Adenosine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.000501	0.00394	CcSEcCtD
Adenosine—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.0005	0.00394	CcSEcCtD
Adenosine—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.000499	0.00392	CcSEcCtD
Adenosine—Acute coronary syndrome—Formoterol—chronic obstructive pulmonary disease	0.000495	0.00389	CcSEcCtD
Adenosine—Acute coronary syndrome—Arformoterol—chronic obstructive pulmonary disease	0.000495	0.00389	CcSEcCtD
Adenosine—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.000492	0.00387	CcSEcCtD
Adenosine—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.000492	0.00387	CcSEcCtD
Adenosine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.000492	0.00387	CcSEcCtD
Adenosine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.000483	0.0038	CcSEcCtD
Adenosine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.000474	0.00373	CcSEcCtD
Adenosine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.000474	0.00372	CcSEcCtD
Adenosine—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00047	0.0037	CcSEcCtD
Adenosine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000465	0.00365	CcSEcCtD
Adenosine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000458	0.0036	CcSEcCtD
Adenosine—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000455	0.00358	CcSEcCtD
Adenosine—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.000454	0.00357	CcSEcCtD
Adenosine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000452	0.00356	CcSEcCtD
Adenosine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000446	0.00351	CcSEcCtD
Adenosine—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000444	0.00349	CcSEcCtD
Adenosine—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.000439	0.00345	CcSEcCtD
Adenosine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000437	0.00344	CcSEcCtD
Adenosine—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000436	0.00343	CcSEcCtD
Adenosine—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000429	0.00338	CcSEcCtD
Adenosine—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000427	0.00336	CcSEcCtD
Adenosine—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000424	0.00334	CcSEcCtD
Adenosine—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000423	0.00333	CcSEcCtD
Adenosine—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000421	0.00331	CcSEcCtD
Adenosine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00042	0.0033	CcSEcCtD
Adenosine—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000418	0.00329	CcSEcCtD
Adenosine—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000418	0.00329	CcSEcCtD
Adenosine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000417	0.00328	CcSEcCtD
Adenosine—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000414	0.00325	CcSEcCtD
Adenosine—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000414	0.00325	CcSEcCtD
Adenosine—ADA—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.000413	0.0125	CbGpPWpGaD
Adenosine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00041	0.00323	CcSEcCtD
Adenosine—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00041	0.00322	CcSEcCtD
Adenosine—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000406	0.00319	CcSEcCtD
Adenosine—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000406	0.00319	CcSEcCtD
Adenosine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000405	0.00318	CcSEcCtD
Adenosine—DPP4—Peptide hormone metabolism—LEP—chronic obstructive pulmonary disease	0.000404	0.0122	CbGpPWpGaD
Adenosine—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000402	0.00317	CcSEcCtD
Adenosine—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000402	0.00317	CcSEcCtD
Adenosine—ADORA2A—GPCRs, Other—CXCR2—chronic obstructive pulmonary disease	0.000402	0.0121	CbGpPWpGaD
Adenosine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000401	0.00315	CcSEcCtD
Adenosine—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000398	0.00313	CcSEcCtD
Adenosine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000398	0.00313	CcSEcCtD
Adenosine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000397	0.00312	CcSEcCtD
Adenosine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000397	0.00312	CcSEcCtD
Adenosine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000395	0.00311	CcSEcCtD
Adenosine—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.00311	CcSEcCtD
Adenosine—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000395	0.00311	CcSEcCtD
Adenosine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000393	0.00309	CcSEcCtD
Adenosine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00039	0.00307	CcSEcCtD
Adenosine—ADORA2A—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	0.000389	0.0118	CbGpPWpGaD
Adenosine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000387	0.00304	CcSEcCtD
Adenosine—Tension—Formoterol—chronic obstructive pulmonary disease	0.000385	0.00303	CcSEcCtD
Adenosine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000385	0.00303	CcSEcCtD
Adenosine—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000384	0.00302	CcSEcCtD
Adenosine—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000384	0.00302	CcSEcCtD
Adenosine—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000383	0.00302	CcSEcCtD
Adenosine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000381	0.003	CcSEcCtD
Adenosine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000381	0.003	CcSEcCtD
Adenosine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00038	0.00299	CcSEcCtD
Adenosine—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000379	0.00298	CcSEcCtD
Adenosine—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000379	0.00298	CcSEcCtD
Adenosine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000375	0.00295	CcSEcCtD
Adenosine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000367	0.00289	CcSEcCtD
Adenosine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000367	0.00289	CcSEcCtD
Adenosine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.00286	CcSEcCtD
Adenosine—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.00285	CcSEcCtD
Adenosine—ADORA2B—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.000362	0.0109	CbGpPWpGaD
Adenosine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000361	0.00284	CcSEcCtD
Adenosine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00036	0.00283	CcSEcCtD
Adenosine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00036	0.00283	CcSEcCtD
Adenosine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00036	0.00283	CcSEcCtD
Adenosine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00036	0.00283	CcSEcCtD
Adenosine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000358	0.00282	CcSEcCtD
Adenosine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000358	0.00282	CcSEcCtD
Adenosine—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000358	0.00282	CcSEcCtD
Adenosine—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000356	0.0028	CcSEcCtD
Adenosine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000353	0.00278	CcSEcCtD
Adenosine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000351	0.00276	CcSEcCtD
Adenosine—Affect lability—Prednisolone—chronic obstructive pulmonary disease	0.000347	0.00273	CcSEcCtD
Adenosine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000347	0.00273	CcSEcCtD
Adenosine—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000347	0.00273	CcSEcCtD
Adenosine—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000347	0.00273	CcSEcCtD
Adenosine—Cough—Formoterol—chronic obstructive pulmonary disease	0.000342	0.00269	CcSEcCtD
Adenosine—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000342	0.00269	CcSEcCtD
Adenosine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00034	0.00268	CcSEcCtD
Adenosine—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000339	0.00267	CcSEcCtD
Adenosine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000339	0.00266	CcSEcCtD
Adenosine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000339	0.00266	CcSEcCtD
Adenosine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.00266	CcSEcCtD
Adenosine—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000335	0.00264	CcSEcCtD
Adenosine—Cough—Montelukast—chronic obstructive pulmonary disease	0.000335	0.00264	CcSEcCtD
Adenosine—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000334	0.00263	CcSEcCtD
Adenosine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000334	0.00263	CcSEcCtD
Adenosine—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000334	0.00263	CcSEcCtD
Adenosine—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000334	0.00263	CcSEcCtD
Adenosine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000333	0.00262	CcSEcCtD
Adenosine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000333	0.00262	CcSEcCtD
Adenosine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000333	0.00262	CcSEcCtD
Adenosine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000332	0.00261	CcSEcCtD
Adenosine—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00033	0.00259	CcSEcCtD
Adenosine—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00033	0.00259	CcSEcCtD
Adenosine—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000327	0.00257	CcSEcCtD
Adenosine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000327	0.00257	CcSEcCtD
Adenosine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000327	0.00257	CcSEcCtD
Adenosine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000326	0.00256	CcSEcCtD
Adenosine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.00256	CcSEcCtD
Adenosine—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000323	0.00254	CcSEcCtD
Adenosine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00032	0.00252	CcSEcCtD
Adenosine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00032	0.00252	CcSEcCtD
Adenosine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.00251	CcSEcCtD
Adenosine—ADORA2A—HIF-2-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000316	0.00954	CbGpPWpGaD
Adenosine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000315	0.00248	CcSEcCtD
Adenosine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000315	0.00248	CcSEcCtD
Adenosine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000314	0.00247	CcSEcCtD
Adenosine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000313	0.00247	CcSEcCtD
Adenosine—DPP4—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.000313	0.00946	CbGpPWpGaD
Adenosine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000312	0.00246	CcSEcCtD
Adenosine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000312	0.00246	CcSEcCtD
Adenosine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000311	0.00245	CcSEcCtD
Adenosine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00031	0.00244	CcSEcCtD
Adenosine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000308	0.00243	CcSEcCtD
Adenosine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000302	0.00238	CcSEcCtD
Adenosine—ADORA2B—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	0.0003	0.00905	CbGpPWpGaD
Adenosine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000299	0.00235	CcSEcCtD
Adenosine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000299	0.00235	CcSEcCtD
Adenosine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000297	0.00234	CcSEcCtD
Adenosine—ADA—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.000297	0.00896	CbGpPWpGaD
Adenosine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000295	0.00232	CcSEcCtD
Adenosine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000292	0.0023	CcSEcCtD
Adenosine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.0023	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000292	0.00229	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000292	0.00229	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000286	0.00225	CcSEcCtD
Adenosine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000285	0.00224	CcSEcCtD
Adenosine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000285	0.00224	CcSEcCtD
Adenosine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000285	0.00224	CcSEcCtD
Adenosine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000285	0.00224	CcSEcCtD
Adenosine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.00222	CcSEcCtD
Adenosine—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000281	0.00221	CcSEcCtD
Adenosine—ADA—p73 transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.00028	0.00846	CbGpPWpGaD
Adenosine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000279	0.00219	CcSEcCtD
Adenosine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000278	0.00219	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000275	0.00217	CcSEcCtD
Adenosine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000274	0.00215	CcSEcCtD
Adenosine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000274	0.00215	CcSEcCtD
Adenosine—ADA—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000272	0.00823	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000271	0.0082	CbGpPWpGaD
Adenosine—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.00213	CcSEcCtD
Adenosine—ADORA2A—Monoamine Transport—IL1B—chronic obstructive pulmonary disease	0.00027	0.00814	CbGpPWpGaD
Adenosine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.00212	CcSEcCtD
Adenosine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.00211	CcSEcCtD
Adenosine—Pain—Montelukast—chronic obstructive pulmonary disease	0.000268	0.00211	CcSEcCtD
Adenosine—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000268	0.00211	CcSEcCtD
Adenosine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000267	0.0021	CcSEcCtD
Adenosine—DPP4—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000266	0.00804	CbGpPWpGaD
Adenosine—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000266	0.0021	CcSEcCtD
Adenosine—ADORA2B—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000266	0.00803	CbGpPWpGaD
Adenosine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000265	0.00209	CcSEcCtD
Adenosine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000265	0.00208	CcSEcCtD
Adenosine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000263	0.00207	CcSEcCtD
Adenosine—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000263	0.00207	CcSEcCtD
Adenosine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000262	0.00206	CcSEcCtD
Adenosine—ADK—Metabolism—APIP—chronic obstructive pulmonary disease	0.000261	0.00789	CbGpPWpGaD
Adenosine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000258	0.00203	CcSEcCtD
Adenosine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000254	0.002	CcSEcCtD
Adenosine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000254	0.002	CcSEcCtD
Adenosine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000252	0.00198	CcSEcCtD
Adenosine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000252	0.00198	CcSEcCtD
Adenosine—ADORA2A—GPCRs, Other—ADRB2—chronic obstructive pulmonary disease	0.000252	0.00761	CbGpPWpGaD
Adenosine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00025	0.00197	CcSEcCtD
Adenosine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00025	0.00196	CcSEcCtD
Adenosine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00025	0.00196	CcSEcCtD
Adenosine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000249	0.00196	CcSEcCtD
Adenosine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000248	0.00195	CcSEcCtD
Adenosine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000248	0.00195	CcSEcCtD
Adenosine—ADORA1—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000244	0.00736	CbGpPWpGaD
Adenosine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000244	0.00192	CcSEcCtD
Adenosine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000243	0.00191	CcSEcCtD
Adenosine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00024	0.00189	CcSEcCtD
Adenosine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000236	0.00185	CcSEcCtD
Adenosine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000236	0.00185	CcSEcCtD
Adenosine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000236	0.00185	CcSEcCtD
Adenosine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000231	0.00182	CcSEcCtD
Adenosine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00023	0.00181	CcSEcCtD
Adenosine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00023	0.00181	CcSEcCtD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000228	0.00688	CbGpPWpGaD
Adenosine—ADORA1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000226	0.00683	CbGpPWpGaD
Adenosine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000225	0.00177	CcSEcCtD
Adenosine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000223	0.00175	CcSEcCtD
Adenosine—ADORA1—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.000221	0.00667	CbGpPWpGaD
Adenosine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000218	0.00171	CcSEcCtD
Adenosine—ADORA2A—HIF-2-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.000217	0.00656	CbGpPWpGaD
Adenosine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000217	0.00171	CcSEcCtD
Adenosine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000212	0.00166	CcSEcCtD
Adenosine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000212	0.00166	CcSEcCtD
Adenosine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000207	0.00163	CcSEcCtD
Adenosine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000203	0.0016	CcSEcCtD
Adenosine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000203	0.0016	CcSEcCtD
Adenosine—ADORA1—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000203	0.00612	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000202	0.0061	CbGpPWpGaD
Adenosine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000202	0.00159	CcSEcCtD
Adenosine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000202	0.00159	CcSEcCtD
Adenosine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000202	0.00159	CcSEcCtD
Adenosine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000202	0.00159	CcSEcCtD
Adenosine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.00158	CcSEcCtD
Adenosine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000201	0.00158	CcSEcCtD
Adenosine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.0002	0.00157	CcSEcCtD
Adenosine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.00157	CcSEcCtD
Adenosine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000199	0.00157	CcSEcCtD
Adenosine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000198	0.00155	CcSEcCtD
Adenosine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000197	0.00155	CcSEcCtD
Adenosine—ADORA2A—GPCRs, Other—HTR2A—chronic obstructive pulmonary disease	0.000197	0.00595	CbGpPWpGaD
Adenosine—ADORA2A—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	0.000197	0.00594	CbGpPWpGaD
Adenosine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00154	CcSEcCtD
Adenosine—ADORA2A—Monoamine Transport—TNF—chronic obstructive pulmonary disease	0.000196	0.0059	CbGpPWpGaD
Adenosine—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000195	0.00153	CcSEcCtD
Adenosine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.00153	CcSEcCtD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000194	0.00585	CbGpPWpGaD
Adenosine—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000194	0.00152	CcSEcCtD
Adenosine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000192	0.00151	CcSEcCtD
Adenosine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000191	0.0015	CcSEcCtD
Adenosine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.0015	CcSEcCtD
Adenosine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.0015	CcSEcCtD
Adenosine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00019	0.0015	CcSEcCtD
Adenosine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00019	0.0015	CcSEcCtD
Adenosine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00149	CcSEcCtD
Adenosine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.00147	CcSEcCtD
Adenosine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000186	0.00146	CcSEcCtD
Adenosine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.00145	CcSEcCtD
Adenosine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000183	0.00144	CcSEcCtD
Adenosine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00018	0.00142	CcSEcCtD
Adenosine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.00141	CcSEcCtD
Adenosine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000179	0.00141	CcSEcCtD
Adenosine—ADA—Metabolism—APIP—chronic obstructive pulmonary disease	0.000178	0.00537	CbGpPWpGaD
Adenosine—ADORA2A—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000175	0.00527	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000174	0.00524	CbGpPWpGaD
Adenosine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000173	0.00136	CcSEcCtD
Adenosine—ADK—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000173	0.00523	CbGpPWpGaD
Adenosine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000171	0.00134	CcSEcCtD
Adenosine—ADORA2A—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.00017	0.00515	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000169	0.00511	CbGpPWpGaD
Adenosine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000169	0.00133	CcSEcCtD
Adenosine—ADK—Metabolism—GC—chronic obstructive pulmonary disease	0.000168	0.00509	CbGpPWpGaD
Adenosine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000168	0.00132	CcSEcCtD
Adenosine—ADORA2B—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000167	0.00504	CbGpPWpGaD
Adenosine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000165	0.00129	CcSEcCtD
Adenosine—SLC28A3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000159	0.00479	CbGpPWpGaD
Adenosine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000158	0.00125	CcSEcCtD
Adenosine—ADA—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000158	0.00476	CbGpPWpGaD
Adenosine—ADK—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000157	0.00473	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000157	0.00472	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000156	0.00471	CbGpPWpGaD
Adenosine—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.00122	CcSEcCtD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00015	0.00452	CbGpPWpGaD
Adenosine—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.00117	CcSEcCtD
Adenosine—ADORA1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000148	0.00445	CbGpPWpGaD
Adenosine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000145	0.00114	CcSEcCtD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000143	0.00432	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000142	0.00429	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—KL—chronic obstructive pulmonary disease	0.000142	0.00429	CbGpPWpGaD
Adenosine—ADORA1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000142	0.00428	CbGpPWpGaD
Adenosine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00112	CcSEcCtD
Adenosine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000141	0.00111	CcSEcCtD
Adenosine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000138	0.00109	CcSEcCtD
Adenosine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000138	0.00108	CcSEcCtD
Adenosine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000136	0.00107	CcSEcCtD
Adenosine—SLC28A3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000134	0.00406	CbGpPWpGaD
Adenosine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000134	0.00105	CcSEcCtD
Adenosine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000133	0.00105	CcSEcCtD
Adenosine—ADA—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000133	0.00401	CbGpPWpGaD
Adenosine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000131	0.00103	CcSEcCtD
Adenosine—ADORA2B—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.00013	0.00394	CbGpPWpGaD
Adenosine—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00013	0.00102	CcSEcCtD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000128	0.00386	CbGpPWpGaD
Adenosine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.001	CcSEcCtD
Adenosine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000991	CcSEcCtD
Adenosine—ADORA1—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000126	0.0038	CbGpPWpGaD
Adenosine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000975	CcSEcCtD
Adenosine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000123	0.000967	CcSEcCtD
Adenosine—DPP4—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000123	0.00371	CbGpPWpGaD
Adenosine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000958	CcSEcCtD
Adenosine—ADORA2B—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000122	0.00367	CbGpPWpGaD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000122	0.00367	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000121	0.00365	CbGpPWpGaD
Adenosine—ADA—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000118	0.00355	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—HDAC2—chronic obstructive pulmonary disease	0.000118	0.00355	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000117	0.00354	CbGpPWpGaD
Adenosine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000903	CcSEcCtD
Adenosine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000902	CcSEcCtD
Adenosine—ADA—Metabolism—GC—chronic obstructive pulmonary disease	0.000115	0.00346	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000114	0.00344	CbGpPWpGaD
Adenosine—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00089	CcSEcCtD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000112	0.00337	CbGpPWpGaD
Adenosine—ADORA1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000111	0.00335	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.00011	0.00334	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.00011	0.00333	CbGpPWpGaD
Adenosine—ADORA2A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.00011	0.00331	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—KL—chronic obstructive pulmonary disease	0.000109	0.0033	CbGpPWpGaD
Adenosine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.00086	CcSEcCtD
Adenosine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000859	CcSEcCtD
Adenosine—ADORA2B—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000109	0.00329	CbGpPWpGaD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000109	0.00328	CbGpPWpGaD
Adenosine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000854	CcSEcCtD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—ERBB3—chronic obstructive pulmonary disease	0.000107	0.00322	CbGpPWpGaD
Adenosine—ADA—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000106	0.00321	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000103	0.00312	CbGpPWpGaD
Adenosine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.00081	CcSEcCtD
Adenosine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000787	CcSEcCtD
Adenosine—ADORA1—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	9.88e-05	0.00298	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	9.81e-05	0.00296	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	9.73e-05	0.00294	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	9.72e-05	0.00293	CbGpPWpGaD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	9.5e-05	0.00287	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	9.39e-05	0.00284	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	9.39e-05	0.00283	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	9.33e-05	0.00282	CbGpPWpGaD
Adenosine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	9.28e-05	0.00073	CcSEcCtD
Adenosine—ADORA1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	9.26e-05	0.00279	CbGpPWpGaD
Adenosine—ADK—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.2e-05	0.00278	CbGpPWpGaD
Adenosine—ADK—Metabolism—GCLC—chronic obstructive pulmonary disease	9.1e-05	0.00275	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	9.06e-05	0.00273	CbGpPWpGaD
Adenosine—Asthenia—Prednisone—chronic obstructive pulmonary disease	9.04e-05	0.000711	CcSEcCtD
Adenosine—ADORA2B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	8.91e-05	0.00269	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	8.61e-05	0.0026	CbGpPWpGaD
Adenosine—ADORA2A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	8.56e-05	0.00259	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	8.51e-05	0.00257	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	8.39e-05	0.00253	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	8.34e-05	0.00252	CbGpPWpGaD
Adenosine—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.33e-05	0.000655	CcSEcCtD
Adenosine—ADK—Metabolism—CTGF—chronic obstructive pulmonary disease	8.3e-05	0.00251	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	8.27e-05	0.0025	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—ERBB3—chronic obstructive pulmonary disease	8.19e-05	0.00247	CbGpPWpGaD
Adenosine—SLC28A3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.07e-05	0.00244	CbGpPWpGaD
Adenosine—Vomiting—Prednisone—chronic obstructive pulmonary disease	8.01e-05	0.00063	CcSEcCtD
Adenosine—ADORA2A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	7.99e-05	0.00241	CbGpPWpGaD
Adenosine—Rash—Prednisone—chronic obstructive pulmonary disease	7.94e-05	0.000625	CcSEcCtD
Adenosine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	7.93e-05	0.000624	CcSEcCtD
Adenosine—Headache—Prednisone—chronic obstructive pulmonary disease	7.89e-05	0.000621	CcSEcCtD
Adenosine—DPP4—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	7.88e-05	0.00238	CbGpPWpGaD
Adenosine—ADK—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.65e-05	0.00231	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	7.63e-05	0.0023	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	7.63e-05	0.0023	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	7.57e-05	0.00229	CbGpPWpGaD
Adenosine—Nausea—Prednisone—chronic obstructive pulmonary disease	7.48e-05	0.000588	CcSEcCtD
Adenosine—ADORA1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	7.38e-05	0.00223	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	7.34e-05	0.00222	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	7.32e-05	0.00221	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	7.25e-05	0.00219	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	7.24e-05	0.00218	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	7.15e-05	0.00216	CbGpPWpGaD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	6.9e-05	0.00208	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	6.9e-05	0.00208	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.53e-05	0.00197	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	6.44e-05	0.00194	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	6.39e-05	0.00193	CbGpPWpGaD
Adenosine—ADK—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.38e-05	0.00193	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	6.32e-05	0.00191	CbGpPWpGaD
Adenosine—ADK—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.29e-05	0.0019	CbGpPWpGaD
Adenosine—ADA—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.26e-05	0.00189	CbGpPWpGaD
Adenosine—ADA—Metabolism—GCLC—chronic obstructive pulmonary disease	6.18e-05	0.00187	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	6.15e-05	0.00186	CbGpPWpGaD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.87e-05	0.00177	CbGpPWpGaD
Adenosine—ADK—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.86e-05	0.00177	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	5.85e-05	0.00177	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	5.65e-05	0.00171	CbGpPWpGaD
Adenosine—ADA—Metabolism—CTGF—chronic obstructive pulmonary disease	5.64e-05	0.0017	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	5.59e-05	0.00169	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	5.59e-05	0.00169	CbGpPWpGaD
Adenosine—ADK—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.56e-05	0.00168	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5.55e-05	0.00168	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.5e-05	0.00166	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.26e-05	0.00159	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.26e-05	0.00159	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	5.23e-05	0.00158	CbGpPWpGaD
Adenosine—ADA—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.2e-05	0.00157	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	5.13e-05	0.00155	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	5.07e-05	0.00153	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.99e-05	0.00151	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.81e-05	0.00145	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.75e-05	0.00143	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	4.7e-05	0.00142	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.67e-05	0.00141	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—chronic obstructive pulmonary disease	4.63e-05	0.0014	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	4.53e-05	0.00137	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.47e-05	0.00135	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.47e-05	0.00135	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.37e-05	0.00132	CbGpPWpGaD
Adenosine—ADA—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.34e-05	0.00131	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.28e-05	0.00129	CbGpPWpGaD
Adenosine—ADA—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.28e-05	0.00129	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.25e-05	0.00128	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.09e-05	0.00123	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.04e-05	0.00122	CbGpPWpGaD
Adenosine—ADA—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.99e-05	0.0012	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	3.96e-05	0.0012	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.85e-05	0.00116	CbGpPWpGaD
Adenosine—ADK—Metabolism—ALB—chronic obstructive pulmonary disease	3.78e-05	0.00114	CbGpPWpGaD
Adenosine—ADA—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.78e-05	0.00114	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.71e-05	0.00112	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.67e-05	0.00111	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	3.63e-05	0.0011	CbGpPWpGaD
Adenosine—ADK—Metabolism—NOS3—chronic obstructive pulmonary disease	3.61e-05	0.00109	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.61e-05	0.00109	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.58e-05	0.00108	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	3.56e-05	0.00108	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	3.56e-05	0.00107	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.45e-05	0.00104	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.45e-05	0.00104	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.3e-05	0.000996	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.28e-05	0.00099	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.27e-05	0.000987	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.16e-05	0.000953	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.04e-05	0.000918	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.97e-05	0.000897	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.95e-05	0.00089	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.87e-05	0.000866	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.81e-05	0.000847	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—IL6—chronic obstructive pulmonary disease	2.74e-05	0.000826	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.7e-05	0.000815	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.68e-05	0.000809	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.58e-05	0.000779	CbGpPWpGaD
Adenosine—ADA—Metabolism—ALB—chronic obstructive pulmonary disease	2.57e-05	0.000775	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.53e-05	0.000763	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.53e-05	0.000762	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.51e-05	0.000757	CbGpPWpGaD
Adenosine—ADA—Metabolism—NOS3—chronic obstructive pulmonary disease	2.46e-05	0.000742	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.4e-05	0.000724	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.35e-05	0.000709	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.29e-05	0.000693	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.28e-05	0.000688	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.19e-05	0.000662	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.17e-05	0.000654	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.04e-05	0.000616	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.97e-05	0.000595	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.95e-05	0.000589	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.94e-05	0.000585	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.88e-05	0.000568	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.8e-05	0.000543	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.77e-05	0.000535	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.76e-05	0.000531	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.69e-05	0.000511	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.68e-05	0.000506	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.6e-05	0.000483	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.59e-05	0.000481	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.57e-05	0.000475	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.53e-05	0.000461	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.52e-05	0.000458	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.44e-05	0.000435	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.36e-05	0.000409	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.29e-05	0.000391	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.29e-05	0.000391	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.29e-05	0.000389	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.24e-05	0.000373	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.23e-05	0.00037	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.19e-05	0.000359	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.18e-05	0.000356	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.17e-05	0.000352	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.1e-05	0.000332	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.05e-05	0.000316	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.01e-05	0.000305	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	9.95e-06	0.0003	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.91e-06	0.000299	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.78e-06	0.000295	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.46e-06	0.000286	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.95e-06	0.00027	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.5e-06	0.000257	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.32e-06	0.000251	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.8e-06	0.000236	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.65e-06	0.000231	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.61e-06	0.00023	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.42e-06	0.000194	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.88e-06	0.000177	CbGpPWpGaD
